The cell used in adoptive immunotherapy must have strong cytotoxic and proliferative ability, so CIK cell is thought of the new generation anti-tumor adoptive immunity treatment.
用于过继免疫治疗的活性细胞必须具有较强的细胞活性和增殖力，CIK细胞被认为是新一代抗肿瘤过继细胞免疫治疗的首选方案。
CONCLUSION: CIK cell transfusion after micro-invasive treatments may improve the immunologic function in HCC patients, and play an important role in reducing the recurrence rate of HCC.
结论：微创治疗后联合cik细胞免疫治疗可提高肝癌患者的免疫功能，对降低肝癌的复发率具有重要作用。
CONCLUSION: CIK cell transfusion after micro-invasive treatments may improve the immunologic function in HCC patients, and play an important role in reducing the recurrence rate of HCC.
结论：微创治疗后联合cik细胞免疫治疗可提高肝癌患者的免疫功能，对降低肝癌的复发率具有重要作用。
应用推荐